scispace - formally typeset
J

Jeffrey E. Grice

Researcher at University of Queensland

Publications -  150
Citations -  5537

Jeffrey E. Grice is an academic researcher from University of Queensland. The author has contributed to research in topics: Human skin & Stratum corneum. The author has an hindex of 36, co-authored 145 publications receiving 4541 citations. Previous affiliations of Jeffrey E. Grice include Greenslopes Private Hospital & Australian National University.

Papers
More filters
Journal ArticleDOI

Nanoparticles and microparticles for skin drug delivery

TL;DR: Unpublished clinical data on nanoparticle penetration and previously published reports support the hypothesis that nanoparticles >10nm in diameter are unlikely to penetrate through the stratum corneum into viable human skin but will accumulate in the hair follicle openings, especially after massage.
Journal ArticleDOI

Skin models for the testing of transdermal drugs

TL;DR: This review discusses the alternative skin models that have been developed as surrogates for normal and diseased skin and examines the concepts of using model systems for in vitro–in vivo correlation and the demonstration of bioequivalence.
Journal ArticleDOI

Topical Nano and Microemulsions for Skin Delivery.

TL;DR: The mechanism of skin delivery across the stratum corneum and via hair follicles is reviewed and the composition and characterization of ME and NE for topical and transdermal delivery is focused on.
Journal ArticleDOI

Topical and cutaneous delivery using nanosystems

TL;DR: How nanosystems are being increasingly exploited for topical and cutaneous delivery, particularly for these previously difficult substances is described, which is driven by the development of novel technologies, which include minimally invasive delivery systems and more precise fabrication techniques.
Journal ArticleDOI

Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies.

TL;DR: This overview on skin delivery considers the evolution of the principles of percutaneous ab-sorption and skin products from ancient times to today and the development of technologies to effectively and quantitatively deliver solutes across this barrier to specific target sites in the skin and beyond.